MBD2 and melanoma: Deletion of the demethylase ALKBH5 inhibited the recruitment of immunosuppressive cells (Treg and MDSC) through targeting the key enzyme of lactate transport MCT4/SLC16A3 and decreasing the extracellular lactate concentration, which subsequently resulted in the sensitization of anti-PD-1 therapy in melanoma cells (45).